Unlikely to cause harm — often a labeling or packaging issue.
Labeling: Incorrect or missing package insert.
| Brand name | BIMATOPROST |
| Generic name | BIMATOPROST |
| Active ingredient(s) | BIMATOPROST |
| Distributed by / for | Sandoz Inc |
| NDC | 0781-6206-93 |
| Full product label | Bimatoprost Ophthalmic Solution 0.03%, Rx Only, For Topical Application to the Upper Eyelid, Sterile, a) 3 mL bottle NDC 0781-6206-93, b) 5 mL bottle NDC 0781-6206-75, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc., Princeton, NJ 08540, Product of Argentina. |
| Recalling firm | Sandoz Inc |
| Distribution | Nationwide in the U.S. |
| Quantity | 346,929 bottles |
| Recall initiated | 2019-10-17 |
| Report date | 2019-11-06 |
| Recall completed | 2022-01-19 |
| Recall number | D-0161-2020 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗